Research Paper Volume 12, Issue 13 pp 13281—13296

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer

Figure 2. (AR) mRNA expression levels of SLC family members in ovarian cancer (426 samples) and normal ovarian tissues (88 samples) (GEPIA). *P < 0.01. SLC, solute carrier.